News

StopAfib.org founder and CEO Mellanie True Hills announced the annual 2018 Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference, which will take place August 3-5 at the Fairmont Dallas. "Our annual Atrial Fibrillation...

iRhythm Technologies, Inc., a leading digital health care solutions company focused on the advancement of cardiac care, announced that results of the mHealth Screening to Prevent Strokes (mSToPS) study, which showed increased detection of...

The American Heart Association recently selected Northwestern Medicine as one of six centers to be part of a new, grant-funded national network dedicated to researching and understanding the causes of atrial fibrillation, the most common type...

Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation (AFib), new research from UC Davis physicians shows. Ablation...

Verseon will be starting a first-in-human phase I trial in Australia for its lead-PROAC (PRecision Oral AntiCoagulant) VE-1902, which has successfully completed regulatory toxicology studies and was well-tolerated in 28-day repeat...

HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June...

Correvio Pharma Corp., a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients, announced that it has received a response from the...

Roche announced plans to launch the CoaguChek Vantus system, the first self-testing device for coagulation monitoring with built-in Bluetooth technology. Patient self-testing with the Bluetooth-enabled CoaguChek Vantus system allows for a new...

Royal Philips, a global leader in health technology, announced that it has signed an agreement to acquire EPD Solutions, an innovator in image-guided procedures for cardiac arrhythmias (heart rhythm disorders). EPD’s cardiac imaging and...

CardioNXT and AFTx, related privately-held medical device companies, jointly announced that the Real-time electrogram Analysis for Drivers of Atrial fibRillation (RADAR) clinical trial has reached full enrollment with 65 treated...